PhaseBio Pharmaceuticals to Participate in Upcoming Investor Conferences

Author's Avatar
Feb 27, 2021
Article's Main Image

PhaseBio+Pharmaceuticals%2C+Inc. (Nasdaq: PHAS), a clinical-stage biopharmaceutical company focused on the development and commercialization of novel therapies for cardiopulmonary diseases, today announced that the company will be participating in two upcoming virtual investor conferences. Details of the events are as follows: